Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor

Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor

Abstract Background Type 2 diabetes mellitus has become one of the most important public health concerns worldwide. Due to its high prevalence and morbidity, there is an avid necessity to find new therapies that slow the progression and promote the regression of the disease. Imatinib mesylate is a t...

Full description

Bibliographic Details
Main Authors: Miguel Ángel Gómez-Sámano, Jorge Enrique Baquerizo-Burgos, Melissa Fabiola Coronel Coronel, Buileng Daniela Wong-Campoverde, Fernando Villanueva-Martinez, Diego Molina-Botello, Jose Alonso Avila-Rojo, Lucía Palacios-Báez, Daniel Cuevas-Ramos, Francisco Javier Gomez-Perez, Alejandro Zentella-Dehesa, Álvaro Aguayo-González, Alfonso Gulias-Herrero
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Endocrine Disorders
Subjects:
Imatinib
Fasting plasma glucose concentrations
Chronic myeloid leukemia
Gastrointestinal stromal tumor
Type 2 diabetes mellitus
Online Access:http://link.springer.com/article/10.1186/s12902-018-0303-x

Internet

http://link.springer.com/article/10.1186/s12902-018-0303-x

Similar Items